CIK 0001674632 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Beta Bionics, Inc.
Sign in to watch- Ticker
- BBNX
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475386878
- Phone
- 949-427-7785
- Business address
- 11 HUGHES, IRVINE, CA, 92618
- Former names
- Beta Bionics, Inc
- 4 Planned sale Chief Financial Officer sold 8,874 shares at $17.21 ($152,681)
- 4 Planned sale Chief Financial Officer sold 744 shares at $17.00 ($12,649)
- 4 Planned sale Chief Financial Officer sold 382 shares at $17.04 ($6,508)
- 4 Planned sale Chief Commercial Officer sold 370 shares at $16.90 ($6,253)
- 4 Planned sale Chief Product Officer sold 2,650 shares at $22.00 ($58,300)
- 4 Planned sale Chief Commercial Officer sold 821 shares at $20.00 ($16,420)
- 4 Open-market sale Chief Commercial Officer sold 775 shares at $17.35 ($13,446)
- 4 Open-market sale Chief Commercial Officer sold 370 shares at $18.96 ($7,015)
- 4 Planned sale Director sold 6,430 shares at $23.00 ($147,890)
- 4/A Planned sale Chief Commercial Officer sold 35,994 shares at $18.46 ($664,550)
- 4 Planned sale Chief Commercial Officer sold 30,779 shares at $20.13 ($619,640)
- 4 Planned sale Chief Product Officer sold 2,650 shares at $22.00 ($58,300)
- 4 Planned sale Chief Commercial Officer sold 775 shares at $15.52 ($12,028)
- 4 Planned sale Chief Commercial Officer sold 36,870 shares at $18.46 ($680,723)
- 4 Planned sale President & CEO sold 5,641 shares at $20.08 ($113,259)
- 4 Open-market sale Chief Commercial Officer sold 5,327 shares at $19.11 ($101,815)
- 4 Open-market sale Chief Medical Officer sold 4,221 shares at $19.11 ($80,676)
- 4 Open-market sale Chief Product Officer sold 4,375 shares at $19.11 ($83,620)
- 4 Open-market sale Chief Financial Officer sold 6,675 shares at $19.11 ($127,580)
- 4 Open-market sale President & CEO sold 16,867 shares at $19.11 ($322,381)
Page 1 of 7 · 122 filings